Dr. Ritesh Rathore
Claim this profileRoger Williams Medical Center
Area of expertise
Lung Cancer
Ritesh Rathore has run 4 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Ritesh Rathore has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Roger Williams Medical Center
CharterCARE (Roger Williams)
Clinical Trials Ritesh Rathore is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Data Collection
for Cancer Immunotherapy Side Effects
This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.
Recruiting
1 award
N/A
7 criteria
More about Ritesh Rathore
Clinical Trial Related
11 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ritesh Rathore has experience with
- Biospecimen Collection
- Carboplatin
- Crizotinib
- Medical Chart Review
- Gemcitabine Hydrochloride
- Paclitaxel
Breakdown of trials Ritesh Rathore has run
Lung Cancer
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ritesh Rathore specialize in?
Ritesh Rathore focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Ritesh Rathore currently recruiting for clinical trials?
Yes, Ritesh Rathore is currently recruiting for 2 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Ritesh Rathore has studied deeply?
Yes, Ritesh Rathore has studied treatments such as Biospecimen Collection, Carboplatin, Crizotinib.
What is the best way to schedule an appointment with Ritesh Rathore?
Apply for one of the trials that Ritesh Rathore is conducting.
What is the office address of Ritesh Rathore?
The office of Ritesh Rathore is located at: Roger Williams Medical Center, Providence, Rhode Island 02908 United States. This is the address for their practice at the Roger Williams Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.